Company Filing History:
Years Active: 2016
Title: Ashish Keche: Innovator in EP2 Receptor Agonists
Introduction
Ashish Keche is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmacology, particularly in the development of EP2 receptor agonists. His innovative work has led to the creation of novel compounds that have potential therapeutic applications.
Latest Patents
Ashish Keche holds a patent for EP2 receptor agonists. The compounds of formula (1), in which R1, R4, A, and X have specific meanings as described in the patent, are recognized as effective EP2 agonists. This patent highlights his expertise in medicinal chemistry and drug development.
Career Highlights
Keche is currently employed at Takeda GmbH, a global pharmaceutical company known for its commitment to research and development. His role at Takeda allows him to work on cutting-edge projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Throughout his career, Ashish has collaborated with esteemed colleagues such as Angelika Hoffmeyer and Rainer Boer. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Ashish Keche's contributions to the field of EP2 receptor agonists exemplify his dedication to innovation in pharmacology. His work continues to pave the way for advancements in therapeutic solutions.